Abstract
This most common of the sphingolipidoses can be effectively prevented if adult carriers of the recessive anomaly are detected and appropriate pregnancies monitored, followed by therapeutic abortion of homozygous fetuses. The authors describe the research through which an accurate, rapid assay for the enzyme defect was developed and the way in which the findings were applied in a program of mass screening for carriers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
